Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > ¹ÙÀÌ¿ÀÀåºñ > ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ·¦¿Â¾îĨ(Lab-on-a-Chip)
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ·¦¿Â¾îĨ(Lab-on-a-Chip)

Global Biochip Markets: Microarrays and Lab-on-a-Chip

¸®¼­Ä¡»ç BCC Research
¹ßÇàÀÏ 2011³â 08¿ù »óǰÄÚµå 208743
ÆäÀÌÁö Á¤º¸ 376 Pages
°¡°Ý
US $ 4,850 £Ü 5,778,700 PDF by E-mail ( Single User License)
US $ 5,950 £Ü 7,089,400 PDF by E-mail (Business Unit License)
US $ 8,500 £Ü 10,127,700 PDF by E-mail (Enterprise License)


BCC Research ¿¡¼­ 2011³â 08¿ù ¿¡ ¹ßÇàÇÑ ¡¸¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ·¦¿Â¾îĨ(Lab-on-a-Chip)¡¹ º¸°í¼­´Â 376 Pages·Î ±¸¼ºµÇ¾î, US $4,850 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¹ÙÀÌ¿ÀĨ(Biochip) ½ÃÀåÀÇ Àüü ±Ô¸ð´Â 2010³â ¹ÌÈ­ 35¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2011³â ¹ÌÈ­ 39¾ï ´Þ·¯, 2016³â ¹ÌÈ­ 96¾ï ´Þ·¯¿¡ ±ÙÁ¢Çϸç CAGR(º¹ÇÕ¿¬°£¼ºÀå·ü) 19.5%¸¦ ±â·ÏÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ(Biochip) ¾÷°è¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ÇöÀç ¹× ÇâÈÄÀÇ ¹ÙÀÌ¿ÀĨ ¿ëµµ, ½ÃÀå ÇöȲ ¹× 2014³â±îÁöÀÇ È®´ë ¿¹Ãø, Ãֽбâ¼ú µ¿Çâ, ½ÃÀå ÁøÃâ ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.

    Á¦1Àå ¼­·Ð
    Á¦2Àå ¿ä¾à
    Á¦3Àå °³¿ä
    • ¼­·Ð
    • ¹ÙÀÌ¿ÀĨÀÇ Á¾·ù
    • º» º¸°í¼­ÀÇ ¹üÀ§
    • ¹ÙÀÌ¿ÀĨÀÇ ½ÃÀå ÀáÀ缺
    • ¹ÙÀÌ¿ÀĨ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¹ÙÀÌ¿ÀĨ ¾÷°è
    Á¦4Àå ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú
    • ¼­·Ð
    • DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú
    • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú
    • ½ÅÈï ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú
    Á¦5Àå ·¦¿Â¾îĨ(Lab-on-a-Chip) ±â¼ú
    • ¼­·Ð
    • ·¦¿Â¾îĨÀÇ Á¾·ù
      • In Vitro Proteomics
      • Ĩ»ó Àü±â¿µµ¿
      • ±¸Á¶´Ü¹éÁúüÇÐ(Structural Proteomics)
      • Ĩ»ó ¸é¿ªºÐ¼®(Immunoassay)
      • Ĩ»ó MS
      • Ĩ»ó ½ÃÄö½Ì
    • ·¦¿Â¾îĨÀÇ ¿ëµµ
    • ·¦¿Â¾îĨÀÇ ÁÖ¿ä ±â¼ú µ¿Çâ
    • ·¦¿Â¾îĨÀÇ ±â¼úÀû °úÁ¦
    Á¦6Àå Drug Discovery ¹× Drug Development¿¡¼­ÀÇ ¹ÙÀÌ¿ÀĨ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨ ½ÃÀå ¼¼ºÐÈ­
    • Drug Discovery ¹× Drug Development
      • ¾àÁ¦ ¾÷°èÀÇ °úÁ¦
      • Drug Discovery ¹× Drug Development ÇÁ·Î¼¼½º °³¿ä
      • ¾àÁ¦ Ç¥ÀûÀÇ Æ¯Á¤
      • Drug Discovery
      • Drug Discovery ¹× Drug Development ÇÁ·Î¼¼½º¿¡¼­ÀÇ ¿ä±¸
    Á¦7Àå Áø´Ü¿¡¼­ÀÇ ¹ÙÀÌ¿ÀĨ ÀÀ¿ë
    • ¼­·Ð
    • Áø´Ü ¿¬±¸ Åø°úÀÇ Â÷ÀÌ
    • Áø´Ü Ç÷§Æû¿¡ ´ëÇÑ ¹ÙÀÌ¿ÀĨ µµÀÔ ÃËÁø¿äÀÎ
    • ºÐÀÚ Áø´Ü
    • Áø´Ü ½ÃÀå ºÎ¹®
    • °¨¼ö¼º ½ÃÇè°ú ƯÀ̼º
    • ±ÔÁ¦ µ¿Çâ
    • ¹ÙÀÌ¿ÀĨÀÇ ¾Ï¿¡ ´ëÇÑ ÀÀ¿ë
    • ¾ÏÁø´Ü ¿ä¾à
    • ¹ÙÀÌ¿ÀĨÀÇ ¿ÍÆÄ¸° °¨µµ(Warfarin Sensitivity)¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ °¨¿°Áõ Áø´Ü¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ ½Å°æ Áø´Ü¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ ½ÉÀå Áø´Ü¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ ³¶Æ÷¼º ¼¶À¯Áõ¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ Ãâ»ýÀü, Ãâ»ýÈÄ ½ºÅ©¸®´×¿¡ ´ëÇÑ ÀÀ¿ë
    • ¹ÙÀÌ¿ÀĨÀÇ ¸é¿ª Áúȯ Áø´Ü¿¡ ´ëÇÑ ÀÀ¿ë
    • AG-BIO ½ÃÀå¿¡ ´ëÇÑ ÀÀ¿ë
    Á¦8Àå ¹ÙÀÌ¿ÀĨ ¾÷°è
    • Àμö
    • Àü·«Àû Á¦ÈÞ
    • µðÁöÅÐ PCR ¾÷°è
    • ÆéŸÀÌµå ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ¾÷°è
    • Áß±¹ÀÇ ¹ÙÀÌ¿ÀĨ ¾÷°è
    • ·¦¿Â¾îĨ ¾÷°è
    Á¦9Àå ¹ÙÀÌ¿ÀĨ ½ÃÀå
    • ¹ÙÀÌ¿ÀĨ ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå
    • DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå
    • ¹ÙÀÌ¿ÀĨ Áø´Ü ½ÃÀå
    • ¾Ï ¹ÙÀÌ¿ÀĨ ½ÃÀå
    • ÇÁ·ÎÅ×ÀÎ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå
    • ½ÅÈï ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå
    • ·¦¿Â¾îĨ ½ÃÀå
    • Áö¿ªº° ½ÃÀå
    Á¦10Àå Æ¯Çã
    • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ Æ¯Çã
    • ·¦¿Â¾îĨ ƯÇã
    • Â÷¼¼´ë DNA ½ÃÄö½Ì ƯÇã
    Á¦11Àå ±â¾÷ °³¿ä
LSH
Back to Top